Uncategorized

VIDEO: Telemedicine viable option for patients seeking efficient ways to receive health care

by  • 

AUSTIN, Texas — In this exclusive video perspective from GI Outlook 2018, Raymond K. Cross, MD, director of the Inflammatory Bowel Disease Program at the University of Maryland School of Medicine, discusses his presentation on how to best implement telehealth into a medical practice.
His talk highlighted three main reasons physicians should consider implementing telemedicine into their practice.
“Our patients are increasingly technologically savvy, [and] they have access to smart phones,” he told Healio Gastroenterology and Liver Disease. “It’s almost universal, so

Read more →

Uncategorized

Aerie confirms Rhopressa’s mechanism of action in open-angle glaucoma, ocular hypertension

by  • 

Aerie Pharmaceuticals confirmed the effect of Rhopressa on trabecular meshwork outflow in patients with open-angle glaucoma or ocular hypertension, according to the topline results of a double-masked, randomized, placebo-controlled study designed to evaluate the eye drop’s mechanism of action.
The study enrolled patients diagnosed with open-angle glaucoma or ocular hypertension in both eyes who had unmedicated baseline IOP between 20 mm Hg and 30 mm Hg. The study evaluated the effect of Rhopressa (netarsudil ophthalmic solution 0.02%) on aqueous humor dynamics, according to a company

Read more →